z-logo
open-access-imgOpen Access
Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer’s disease
Author(s) -
Ihab Hajjar,
Maureen Okafor,
Limeng Wan,
Zhiyi Yang,
Jonathon A. Nye,
Anastasia Bohsali,
Leslie M. Shaw,
Allan I. Levey,
James J. Lah,
Vince D. Calhoun,
Reneé H. Moore,
Felicia C. Goldstein
Publication year - 2022
Publication title -
brain communications
Language(s) - English
Resource type - Journals
ISSN - 2632-1297
DOI - 10.1093/braincomms/fcac270
Subject(s) - candesartan , biomarker , disease , medicine , alzheimer's disease , oncology , receptor , biology , angiotensin ii , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom